EngPA, MortonJ, DouglassJA, RiedlerJ, WilsonJ, RobertsonCF. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatr Pulmonol, 1996; 21(2):77–83.
3.
DonaldsonSH, BennettWD, ZemanKL, KnowlesMR, TarranR, BoucherRC. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med, 2006; 354(3):241–250.
4.
ElkinsMR, RobinsonM, RoseBR, HarbourC, MoriartyCP, MarksGBet al; National Hypertonic Saline in Cystic Fibrosis (NHSCF) Study Group. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med, 2006; 354(3):229–240.
5.
FlumeP, O'SullivanBP, RobinsonKA, GossCH, MogayzelPJJr, Willey-CourandDBet al; Cystic Fibrosis Foundation Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Crit Care Med, 2007; 176(10):957–969.
6.
O'ConnellOJ, O'FarrellC, HarrisonMJ, EustaceJA, HenryMT, PlantBJ. Nebulized hypertonic saline via positive expiratory pressure versus via jet nebulizer in patients with severe cystic fibrosis. Respir Care, 2011; 56(6):771–775.
7.
RatjenF. Restoring airway surface liquid in cystic fibrosis. N Engl J Med, 2006; 354(3):291–293.
